UCL News


Robin Ali wins ophthalmology research award

16 April 2009


Alcon Research Institute logo ucl.ac.uk/iris/browse/profile?upi=RRALI61" target="_self">Professor Robin Ali
  • UCL Institute of Ophthalmology
  • Alcon Research Institute
  • UCL Global: The Americas
  • Robin Ali, Professor of Human Molecular Genetics at the UCL Institute of Ophthalmology, has won an Alcon Research Institute Award for his outstanding contribution to advancing eye health.

    The award was made in recognition of Professor Ali's work in the development of gene and stem cell therapies for the treatment of retinal disorders. He demonstrated improvement in vision in a patient with an inherited retinal degeneration following gene therapy in a clinical trial in 2008.

    Professor Ali was nominated by previous winners of the award. He will receive $200,000 in unrestricted grant money to continue his research into the underlying causes of eye disease and has been invited to present his research at the 2011 Alcon Researcch Institute symposium.

    Professor Ali said: "I am honoured to have been recognised by this illustrious group of ophthalmic researchers."

    The Alcon Research Institute supports global advancements in eye health by honoring those who make outstanding research contributions to the vision sciences and providing grants to fund ongoing research. This year six awards were made. The institute is part of Alcon, an international eye care company founded in the USA that produces pharmaceutical and consumer products.


    UCL context

    The UCL Institute of Ophthalmology conducts cutting-edge science, attracting researchers of the highest international calibre. The institute is involved in graduate training of research students and its contributions to UCL undergraduate and taught graduate teaching are increasing year by year.

    Related stories

    New PhD studentships in ophthalmology

    Results of world's first gene therapy for inherited blindness show sight improvement

    Fight for sight funding